Search
Markets
News
Analysis
Tools
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
News
All
Editors' Picks
Stocks
Indices
Market Movers
Commodities
Cryptocurrencies
Forex
Technical Analysis
Economic Indicator
Other
Important Only
Fitch Revises New York City's Outlook To Negative
March 20 (Reuters) - FITCH: REVISES NEW YORK CITY'S OUTLOOK TO NEGATIVEFITCH ON NYC: OUTLOOK REVISION REFLECTS POTENTIAL FOR WEAKENING FINANCIAL RESILIENCE, WIDENING OUT-YEAR BUDGET GAPS, UNCERTAIN GAP-CLOSING SOLUTIONSFurther company coverage: [ ]
Reuters
Fri, Mar 20
X-Energy, Inc Announces Initial Public Offering Of Class A Common Stock - SEC Filing
March 20 (Reuters) - SEC Filing:X-ENERGY, INC: ANNOUNCES INITIAL PUBLIC OFFERING OF CLASS A COMMON STOCK - SEC FILINGX-ENERGY, INC. - INTEND TO APPLY TO LIST OUR CLASS A COMMON STOCK ON NASDAQ UNDER THE SYMBOL “XE.”X-ENERGY, INC: J.P. MORGAN, MORGAN STANLEY, JEFFERIES, MOELIS & COMPANY ARE UNDER...
Reuters
Fri, Mar 20
Femasys Enters Omnibus Amendment And Consent Agreement On March 19, 2026 - SEC Filing
March 20 (Reuters) - SEC Filing:FEMASYS INC - ENTERS OMNIBUS AMENDMENT AND CONSENT AGREEMENT ON MARCH 19, 2026 - SEC FILINGFEMASYS INC - AMENDMENT REMOVES SHARE COMBINATION EVENT ADJUSTMENT IN NOTES AND WARRANTS EFFECTIVE DEC 31, 2025 - SEC FILINGSource text: [ID:n0001140361-26-010591]
Reuters
Fri, Mar 20
Regenxbio Enters Settlement And Release Agreement With Glaxosmithkline On March 18, 2026 - SEC Filing
March 20 (Reuters) - SEC Filing:REGENXBIO INC - ENTERS SETTLEMENT AND RELEASE AGREEMENT WITH GLAXOSMITHKLINE ON MARCH 18, 2026 - SEC FILINGREGENXBIO INC - TO PAY $10.0 MILLION TO GLAXOSMITHKLINE FOR ALLEGED UNDERPAYMENT OF SUBLICENSE FEES - SEC FILINGREGENXBIO INC - SETTLEMENT AGREEMENT INCLUDES MUT...
Reuters
Fri, Mar 20
Spruce Biosciences On March 16, Entered Termination Agreement With Kaken Pharmaceutical - SEC Filing
March 20 (Reuters) - SEC Filing:SPRUCE BIOSCIENCES INC - ON MARCH 16, ENTERED TERMINATION AGREEMENT WITH KAKEN PHARMACEUTICAL - SEC FILINGSPRUCE BIOSCIENCES INC - COLLABORATION AGREEMENT WITH KAKEN PHARMACEUTICAL TO TERMINATE EFFECTIVE MARCH 31, 2026 - SEC FILINGSPRUCE BIOSCIENCES INC - ALL LICENSES...
Reuters
Fri, Mar 20
HM Exploration Announces $1.5 Million Life Flow-Through Offering
March 20 (Reuters) - HM Exploration Corp HM.CD:HM EXPLORATION ANNOUNCES $1.5 MILLION LIFE FLOW-THROUGH OFFERINGHM EXPLORATION CORP - TO COMPLETE PRIVATE PLACEMENT FOR UP TO C$1.5 MILLION
Reuters
Fri, Mar 20
Sezzle Dismisses Baker Tilly As Independent Accounting Firm On March 16, 2026 - SEC Filing
March 20 (Reuters) - SEC Filing:SEZZLE INC - DISMISSES BAKER TILLY AS INDEPENDENT ACCOUNTING FIRM ON MARCH 16, 2026 - SEC FILINGSEZZLE: AUDIT FOUND MATERIAL WEAKNESSES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING AS OF DEC 31, 2025 - SEC FILINGSource text: [ID:n0001662991-26-000036]
Reuters
Fri, Mar 20
Goodyear Tire & Rubber Approves Rationalization Plan In EMEA To Improve Its Cost Structure - SEC Filing
March 20 (Reuters) - SEC Filing:GOODYEAR TIRE & RUBBER CO - APPROVES RATIONALIZATION PLAN IN EMEA TO IMPROVE ITS COST STRUCTURE - SEC FILINGGOODYEAR TIRE & RUBBER CO - PROPOSED RESTRUCTURING TO REDUCE NET 400 POSITIONS IN EMEA - SEC FILINGGOODYEAR TIRE & RUBBER CO - EXPECTS PRE-TAX CHAR...
Reuters
Fri, Mar 20
Columbia Sportswear Enters Credit Agreement On March 19, 2026 - SEC Filing
March 20 (Reuters) - SEC Filing:COLUMBIA SPORTSWEAR CO - ENTERS CREDIT AGREEMENT ON MARCH 19, 2026 - SEC FILINGCOLUMBIA SPORTSWEAR CO - CREDIT AGREEMENT PROVIDES FOR UP TO $500 MILLION UNSECURED REVOLVING CREDIT - SEC FILINGCOLUMBIA SPORTSWEAR CO - CREDIT FACILITY MATURES ON MARCH 19, 2031 - SEC FIL...
Reuters
Fri, Mar 20
Eyepoint Files Complaint Against Ocular Therapeutix In Middlesex County Superior Court
March 20 (Reuters) - EyePoint Inc EYPT.O:EYEPOINT INC - FILES COMPLAINT AGAINST OCULAR THERAPEUTIX IN MIDDLESEX COUNTY SUPERIOR COURT FOR COMMONWEALTH OF MASSACHUSETTS ON MARCH 20, 2026EYEPOINT INC - COMPLAINT ALLEGES OCULAR THERAPEUTIX DISSEMINATED FALSE STATEMENTS ABOUT EYEPOINT AND DURAVYU - SEC...
Reuters
Fri, Mar 20
Digital Currency X Technology Entered Into A Share Purchase Agreement With Drivepoint Holdings
March 20 (Reuters) - Digital Currency X Technology Inc DCX.O:DIGITAL CURRENCY X TECHNOLOGY - ENTERED INTO A SHARE PURCHASE AGREEMENT WITH DRIVEPOINT HOLDINGSDIGITAL CURRENCY X TECHNOLOGY- DRIVEPOINT CONDITIONALLY AGREED TO ACQUIRE CHIJET INCDIGITAL CURRENCY X TECHNOLOGY- SALE AND PURCHASE OF ENTIRE ...
Reuters
Fri, Mar 20
Pfizer Recommends Shareholders Reject The Mini-Tender Offer By Tutanota
March 20 (Reuters) - Pfizer Inc PFE.N:PFIZER RECOMMENDS SHAREHOLDERS REJECT THE MINI-TENDER OFFER BY TUTANOTA LLCPFIZER RECOMMENDS SHAREHOLDERS REJECT THE MINI-TENDER OFFER BY TUTANOTA LLCPFIZER - RECEIVED NOTICE OF UNSOLICITED MINI-TENDER OFFERTHAT TUTANOTA LAUNCHES MINI-TENDER OFFER FOR 1 MILLION ...
Reuters
Fri, Mar 20
Fortive Corp On March 17 Enters Third Amended And Restated Credit Agreement With Bank Of America - SEC Filing
March 20 (Reuters) - SEC Filing:FORTIVE CORP - ON MARCH 17, ENTERS THIRD AMENDED AND RESTATED CREDIT AGREEMENT WITH BANK OF AMERICA - SEC FILINGFORTIVE CORP - CREDIT AGREEMENT PROVIDES 5-YEAR REVOLVING FACILITY UP TO $2.0 BILLION WITH MULTICURRENCY BORROWING FEATURE - SEC FILINGFORTIVE CORP - CREDIT...
Reuters
Fri, Mar 20
Court Confirms Zynex Plan Of Reorganization On March 19, 2026 - SEC Filing
March 20 (Reuters) - SEC Filing:ZYNEX INC - COURT CONFIRMS ZYNEX PLAN OF REORGANIZATION ON MARCH 19, 2026 - SEC FILINGZYNEX INC - EXPECTS EFFECTIVE DATE OF PLAN NO LATER THAN MARCH 31, 2026 - SEC FILINGSource text: [ID:n0001104659-26-032723]
Reuters
Fri, Mar 20
Clayton Adams Resigns As CEO Of Cleancore Solutions On March 16, 2026 - SEC Filing
March 20 (Reuters) - SEC Filing:CLEANCORE SOLUTIONS INC - CLAYTON ADAMS RESIGNS AS CEO ON MARCH 16, 2026 - SEC FILINGCLEANCORE SOLUTIONS INC - APPOINTS TYLER HASSEN AS CEO ON MARCH 16, 2026 - SEC FILINGSource text: [ID:n0001213900-26-032356]
Reuters
Fri, Mar 20
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug
March 20 (Reuters) - EyePoint EYPT.O filed a lawsuit on Friday accusing rival Ocular Therapeutix OCUL.O of spreading false or misleading information about EyePoint and its lead experimental eye drug.The complaint was filed in Middlesex County Superior Court for the Commonwealth of Massachusetts.The ...
Reuters
Fri, Mar 20
Trump says US getting close to meeting objectives in Iran war
WASHINGTON, March 20 (Reuters) - President Donald Trump said on Friday the U.S. was getting very close to meeting its objectives as it considers winding down its military efforts in the Iran war and called on countries that use Strait of Hormuz to guard and police it "as necessary." "The...
Reuters
Fri, Mar 20
Trump says US getting close to meeting objectives in Iran war
WASHINGTON, March 20 (Reuters) - President Donald Trump said on Friday the U.S. was getting very close to meeting its objectives as it considers winding down its military efforts in the Iran war and called on countries that use Strait of Hormuz to guard and police it "as necessary."
Reuters
Fri, Mar 20
Eight states ask US judge to temporarily block Nexstar, Tegna merger
By David Shepardson March 20 (Reuters) - Eight states asked a U.S. judge on Friday to issue a temporary restraining order to stop the $3.5 billion merger of Nexstar Media Group and Tegna.On Thursday, the local broadcast station owners received merger approval from the Federal Communications Commi...
Reuters
Fri, Mar 20
Blackstone Private Credit Fund Reported Total Return Of -0.4% In February - FT
March 21 (Reuters) - Financial Times:FLAGSHIP BLACKSTONE CREDIT FUND POSTS FIRST MONTHLY LOSS SINCE 2022 - FTBLACKSTONE PRIVATE CREDIT FUND, KNOWN AS BCRED, REPORTED A TOTAL RETURN OF -0.4 PER CENT IN FEBRUARY- FTBCRED, WROTE DOWN VALUE OF A “SELECT” NUMBER OF LOANS DURING FEBRUARY, INCLUDING DEBT I...
Reuters
Fri, Mar 20
1
...
177
178
179
179
/
300
180
181
...
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free